|
Volumn 64, Issue 3, 2008, Pages
|
Orphan economics: The downside of supply-side pharmacology
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOTROPIN;
COST;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG MANUFACTURE;
ECONOMICS;
EDITORIAL;
ETHICS;
FEE;
HUMAN;
LEGAL ASPECT;
RARE DISEASE;
STANDARD;
ADRENOCORTICOTROPIC HORMONE;
COSTS AND COST ANALYSIS;
DRUG APPROVAL;
DRUG INDUSTRY;
FEES, PHARMACEUTICAL;
HUMANS;
ORPHAN DRUG PRODUCTION;
RARE DISEASES;
|
EID: 55949129683
PISSN: 03645134
EISSN: 15318249
Source Type: Journal
DOI: 10.1002/ana.21432 Document Type: Short Survey |
Times cited : (5)
|
References (0)
|